71 2
J u z ogUnvS i eho Me c] ah n i cT c n l[ dS i H D 01 0/1 5 60 10 8, OI 0 7s 19— 1— 5 88 1
3 () 1— 1, 1 1: 27 6 0 1 57 2
Co r l to a y i n T t l y p o y eCp n n r e a i n An l sso o a m h c t u ta d CD4 Cp n L u tn i H I i f c e te s A e r s c i a ua i n‘ V-n e t d Pa i nt: R t o pe tveEv l to Y migWANG( u n王字明) S u igL A G( h yn I N梁淑英), r nYu(, Ema于二曼) J l gG i i UO(,nn郭金玲) Zz a I李自钊) i o (, h L , Z e NG(哲) Y ki u(玉开) h wA王 uaD杜, ’ He a o i ca d c l a e, h n z o 5 0 3 Ch n n nPr vn i l Me ia d my Z e g h u 4 0 0, i a Ac
2 p r n o E ie ooyadBott ts C l g P biHe l, hn zo nvri, h nz o 5 0 1 C ia De at tf pd mil n i aii, ol e f u l at Z eg h uU i st Z egh u4 0 0, hn me g s sc e o c h e y j etr r D,T C nrl n rvninDe at n O Hel Hea P o i e Z e gh u4 0 0 hn C ne f Al ss D o t a dP eet p r o o o met f at o h f n n rvn h nz o 5 03 C ia c 4 s ttfr net n saeC nrl n rvninHe a rv c l etr r sae o t l n rvnin Z egh u I tue o fci es o t dP eet, n n oi i ne es nr d ee t, h nz o ni I o Di oa o P n aC o f Di C oa P o 4 0 0, hn 5 0 3 C ia
5 p r n Maen l n hl at C r n A oecn H geeS h o P biHel,o g dcl ol e De at tf tra dC i me o a dHel aea d d l e t y in, c o lf u l at TnfMeia l g,
h s o c h i C e Hu zo gU iesyo S i c n cn lg, u a 3 0 0C ia ah n nvri f c n e dT h ooy W h n4 0 3, hn t e a e ◎ Hu z o gUn v r i fS i n ea d T c n l g n p i g rVe lg Be l i e b r 01 a h n i e s y o ce c n e h o o y a d S rn e— r ri He d l e g 2 1 t a n
S m ma y CD4 c u ti t e sa d r t o o ee mi i g ei i i t o ih y a t e a t er— u r: o n s h t n a d meh d f rd tr n n l b l y f rh g l c i n i t g i v r o
vrl h rp HA T a dmo i r gHI/ I i aepo rsin b tt s o wie v i be i ea y( AR ) n nti V A DSds s r ge s . u t d l a a a l at on e o iin y l i e o r e 1 i d s ti g .T i s d x m i e h o r l t n b t e o a y h c t o n n r s u c . m t et s h s t y e a n d t e c re ai ewe n tt ll mp o y e c u t i e n u o
( C)a dCD4c u to V— fce ainsb f r n f rHAART a da sse h rs od TL n o fHI i e tdp t t eo ea dat n n e e, n se sdtet eh ls h o LC f rma i g d cso s a o t h n t t n a d f rmo i r g HAAR . r to p c i es d fT 0 k n e iin b u e i i ai n o n t i t i o o n T A er s e t t y v u
wa efr d a d 6 5HI ifce ainswi LC a dCD4c u tfo fu o nis( h n— sp rome . n 6 V— e tdp t t t T n n e h o n rm o rc u t e S a g
c i Q eh n S e qua dw e h) eeic d di e td . ero orlt na drc ie o e— a. u s a . h n i n i i w r l e t y P asn c
r a o n e r p r s n u nh s u e i e v a i g c aa t rs c f t h r c e it R0C1 r s d TL a d CD4 c u ta e n i e u e . C n we o n f rHAART wa i n f a t c e s d t ssg ii n l i r a e c yn a o ae t r— s mp r d wi p e HAAI’ P< . 1 An o ea 1 o iie c re ai n wa o e ewe n T n c h己 f 001 . v r l p st o l t sn t d b t e LC a d 1 v o
C o n (r— AAR,= .3 P 00 0; ol u AA T r 05,= .0 1. h O u v D4c u t peH T r 0,= . 1 fl w— pH R,= .6 P 0 0 ) T eR C c re 7 - 0 o 0 b t e LC a d CD4 c u t h we a LC 1 0 el/ m c u d p e it ewe n T n o o dt t n s h T 0c l m 2 s o l r d c CD4<2 0 c l/ 0 e l mm。 s’
wi e st i f7 .2 s e ict f6 -5 a r. t as n ivt o 11%. p cf i o 63% t eHAAR . tr1 - nhHAA R,h p h i y i y p T Afe 2 mo t T teo— tmu p e it n f rCD4 c u t< 2 0 c l/ i m r d c i o o o n 0 el mm ̄ sa T 1 0 el/ s wa LC 0 c l mm wi e st i f 3 s, t as n i v t o h i y
6 .7 . n p cf i f7 .4 . ut e n igidc tdta C h n ewa o iv l o— 32% a das e i ct o 4 8% F rh rf dn iae t i y i n h TL c a g sp s iey c r t
r ltdt eae CD4 c a g F 07, - .0 a h mep it f1 .mo t rame ta dteb s p e o h n e( .7 P- 0 0 ) t et on 2 0 1 t i o nhte t n, n et r— h d ci n p i t fT h n ef rCD4 i c e sn s 1 5 c l/ i t o n LC c a g o o o
r a i g wa el mm T n sc a g a eu e n 3 s . LC a d i h n ec n b s d t a u r g t r e r o t n s h n e o V. f ce d v d a sf rma i g d cso s sa s ro a ema k r D4 c u d i a g f o f C n a tc HI i e t d i i iu l o k n e iin n n a o t h i ai n a df r n t r gHAAI i s u c— mi d s ̄ n s b u ei t t n o t ni o mo i i o n n r o r e l t e i g . e i e Ke r s HI AI; vwo d: V/ DS CD4 c u t t tl y h c t o n: i h y a t ea t er v r l h r p o n: o a mp o y e c u t h g l ci n i to ia e a y l v r t
C+ T 1mp o ye C )c u ti ep r h D4 . y h c ts( D4 o n t ei— n h p e a l o s a s e ta o lf rt e lb r t r n - r lb o d i n e s n i1t o o h a o ao y mo i t rn fHI . e tdpain s b t rt ep o r s i n o ig o V i ce te t. oh f r g e so nf o h o ie s a d f r t e s e s e t o h f a y f f d s a e n h a s s m n f t e e nc c o o
i ain swiha v n e m u o s p r s in o DS np t t t d a c d i e m n .u p e so rAl L- J 68 .
a d s g se h tTLC sa c s— fe tv a k r n ug e td ta i o tef c ie m r e
f rg i i o u dng HAART n r s u c .i t d s ti swh r i e o r e1mie et ng e e CD4 c u ti o v ia l I TLC i h e u eulf r o n sn ta alb e m g tb s f o .
hg l cv ni t v a teayr A T z b t i yat eater i l hrp H AR )’, u, h i r o r J w o l wi e t p i ain wa
i ie ue t h x rd d .is a pl to s l td d o t e e— c m p n eo q p e ndr a n si v l e Th r f r . t e s fe uim nt a e ge t n o v d. e eo e i i e ia l o f he p a d e fc i u siue f r s d srb e t nd a c a n fe t i ve s b t t t o CD4 c u tf r t o i rn fi o n he m n t i g o mm u e f ncin o o o n u t f o HI . e td id v d as . V i c e i i u l nf n
m o i rng t e p o r s in o HI A I i r— n t i h r g e so f o V/ DS n e s u c .i ie et s .A1 ug n C i o r e 1 t d s ti L m ng J t ho h i hna HA ART h sbe n e tn i ey u e n HI— e td p te s‘ a e x e sv l s d i V i ce aintL nf。
CD4 mo io i g rm ansu a ia l o a li d v d as n t rn e i n valb e t l n i i u l w i V n e to/ D S n e su isi v si ae t HI if ci n AI .a d fw t de n e tg t d h t ec re ain b t e n CD4 c u ta d TLC n ac ho h o r lt ew e o o n n i o r t
T t mp oyecu tT C i ruie c dd oa l h ct o n (L )s o t l i l e ly n yn u i c mplt b o o n, ih i a y a n x n i e n o ee lod c u t wh c se s ndi e pe sv —
O I p ii e pain s f H V. ostv te t.Th r f e h s t d x m— e eor .t i s y e a u ie h o r lto t e n d t e c rea in bewe n TLC n a d CD 4 c u,a d o nt n e au tdTLC same s r rm o t rn ie s r— v la e a a u ef ni ig d s a ep o o o g e so n u ai fe
t fHAA RT nH I i e td r si n a d c r t vee fc o i V—nfc e p te t. ain s
t m e ur I, o as e’
P e ius t d e d mo srtd r v o s i s e n tae hih u g c nsse y bewe n CD4 c un nd TLC, a tc lry o itnc t e o ta p riu a l .
Y migWA ̄— i hwy 0 0 16cm u n NC E ma: n m2 1@ 2 . l o Th e e r h wa u p re y a g a tfo t e Ke o e r s a c s s p o d b r n m h y Pr— t r
1M ATER I ALSA ND ETH o DS M
jcs nteNa o a S i c et i t n l c n e& T c n lg ia rga h i e eh ooyPl r o rm l P dr gteE eet ieY a Pa eid o hn No ui h l nh Fv—er l P r fC ia( . n v n o 2 0 Z 0 0— 1) 0 9 X10 1 7. 0
11Pa tcpa t . r ii n s
The p oo o a p r v d b h e ia his r t c lw s a p o e y t e M d c lEt c

CD4 lymphocyte count in patients with advanced HIV related Kaposi'_专业资料... Correlation Analysis o... 2人阅读 5页 2.00 Effect of Intermittent....
Correlation between Ultrasonographic Features of HIV/...The cross-check analysis was employed between ...CD4+ T lymphocyte count immune periods, including...
In this analysis, we assess the effect of BMI ...CD41 lymphocyte count and plasma HIV-1 RNA ...The absence of a persistently positive correlation ...
CD4 T cell counts in HIV-1-infected patients ...lymphocyte count testing and therefore has the ...were assessed using Spearman rank correlation tests...
correlation between HIV-specific CD8+ T cell ...lymphocyte (CTL) immune responses are critical in...lanl.gov. 1.7 Statistical analysis Clinical data...
lymphocyte functions including lymphoproliferative ...s correlation were used for analysis of immune ...All of the 25 chronic HBV-infected patients ...
Recognized by Human CD41 Cytotoxic T Lymphocyte...antibody production and by lysing virus-infected ... Analysis of genes coding for nonstructural ...
We determined the absolute count of lymphocyte ...Because of this, a mixed model analysis of ...Alterations in lymphocyte phenotype of infected ...
count, ×1012/l Lymphocyte count, ×109/l ...The Pearson correlation test was used to examine ...A, Quantitative PCR analysis of miR-17-92 ...
Indices: – Total white cell count – Lymphocyte distribution (CD3, CD4,...(safety analysis for DSMB) – SD of IQ = 15 and correlation between ...
热门文档